NCT05057130 2024-04-01
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
Clinical Trials
23 trialsNCT03420014 2023-10-10
FIBROSARC US
Philogen S.p.A.
Phase 2 Unknown
NCT05448820 2023-09-21
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Tracon Pharmaceuticals Inc.
Phase 1/2 Unknown
NCT05747521 2023-02-28
Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma
Henan Cancer Hospital
Phase NA Unknown
NCT04012827 2022-09-07
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05138146 2021-11-30
A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2 Unknown
NCT04910126 2021-06-02
Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT04356872 2020-07-14
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT03002805 2019-08-19
CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
CBA Research
Phase 1 Unknown
NCT03360760 2018-08-28
Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum
Peking University People's Hospital
Phase NA Unknown
NCT02812654 2016-06-24
Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
AC Camargo Cancer Center
Phase 2 Unknown
NCT02587169 2015-10-27
GEIS-27
Broto, Javier MartÃn, M.D.
Phase 1/2 Unknown
NCT00410462 2014-08-08
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown
NCT00020566 2014-06-24
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00718484 2014-01-30
PICASSO
Alaunos Therapeutics
Phase 2 Unknown
NCT00002516 2013-09-17
Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00334854 2013-08-12
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00379457 2013-08-12
Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00204568 2013-01-08
Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
University Hospital Schleswig-Holstein
Phase 2 Unknown
NCT00790244 2011-07-06
SSGXX
Oslo University Hospital
Phase 2 Unknown
NCT00691236 2011-06-23
ZOL
Tata Memorial Hospital
Phase 2/3 Unknown
NCT00339118 2006-06-20
EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
Sheba Medical Center
Phase 4 Unknown
NCT00002318 2005-06-24
A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
NIH AIDS Clinical Trials Information Service
Phase 3 Unknown